Increased endothelial monocyte adhesiveness is related to clinical outcomes in chronic heart failure

Wei-Hsian Yin1, Jaw-Wen Chen, Mason Shing Young

  • 1Division of Cardiology, Department of Internal Medicine, Cheng-Hsin Rehabilitation Medical Center, Taipei-Veterans General Hospital, Taiwan.

Insights

Increased adhesion of peripheral blood mononuclear cells (PBMCs) to endothelial cells is linked to worse outcomes in chronic heart failure (CHF) patients, suggesting a role in disease progression.

Area of Science:

  • Cardiovascular Medicine
  • Immunology
  • Pathophysiology

Background:

  • Chronic heart failure (CHF) is associated with vascular inflammation and endothelial dysfunction.
  • Activated peripheral blood mononuclear cells (PBMCs) and their adhesion to endothelium may play a role in CHF pathophysiology.
  • This study investigates the clinical significance of PBMC activity in CHF patients.

Purpose of the Study:

  • To investigate the clinical significance of PBMC activity in CHF patients.
  • To determine if PBMC adhesiveness to endothelial cells correlates with disease severity and clinical outcomes.
  • To explore the pathophysiological relevance of PBMC-endothelial cell interactions in CHF progression.

Main Methods:

  • PBMCs were isolated from 34 CHF patients, 10 healthy controls, and 17 disease controls.
  • PBMC adhesiveness to human aortic endothelial cells (HAECs) was measured with and without TNF-alpha stimulation.
  • Major adverse cardiac events were tracked over a median follow-up of 182 days.

Main Results:

  • PBMCs from severe CHF patients showed significantly higher adhesion to HAECs compared to controls and mild CHF patients.
  • Endothelial adhesiveness of PBMCs positively correlated with circulating cell adhesion molecules (CAMs).
  • Higher PBMC-endothelial cell adhesion levels were associated with significantly worse event-free survival (log rank test, p=0.0139).

Conclusions:

  • Increased endothelial adhesiveness of PBMCs is a feature of severe CHF.
  • This increased adhesiveness correlates with clinical outcomes, suggesting prognostic value.
  • PBMC-endothelial cell interactions are likely pathophysiologically relevant to CHF progression.
Abstract

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...